Litigation Details for UNITED THERAPEUTICS CORPORATION v. VANDERBILT UNIVERSITY (D.C. 2016)
✉ Email this page to a colleague
UNITED THERAPEUTICS CORPORATION v. VANDERBILT UNIVERSITY (D.C. 2016)
Docket | ⤷ Sign Up | Date Filed | 2016-11-07 |
Court | District Court, District of Columbia | Date Terminated | |
Cause | 28:1332 Diversity-Breach of Contract | Assigned To | |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,521,212; 6,756,033 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in UNITED THERAPEUTICS CORPORATION v. VANDERBILT UNIVERSITY
Details for UNITED THERAPEUTICS CORPORATION v. VANDERBILT UNIVERSITY (D.C. 2016)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2016-11-07 | 1 | The research resulted in U.S. Patent Nos. 6,521,212 (the “’212 patent”) (attached as Exhibit B hereto…filed the patent applications that subsequently issued as the ’212 patent and the ’033 patent, respectively… ownership of the Patents. 20. The Patents issued in February 2003 (the ’212 patent) and June 2004 (the…6,756,033 (the “’033 patent”) (attached as Exhibit C hereto) (collectively the “Patents”). ln 2009, UTC obtained…the Patents, and by failing to cooperate with UTC in connection with UTC’s defense of the Patents.` Vanderbilt | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |